ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

NCI Using Three Methods To Encourage Grants In Programs

August 25, 1978

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990